echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Base drug plus long prescription, base drug core drug catalog or in the brewing! These varieties form the focus.

    Base drug plus long prescription, base drug core drug catalog or in the brewing! These varieties form the focus.

    • Last Update: 2020-07-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to industry sources, on July 13th and 14th, the National Health and Care Commission held an online meeting on the management of essential drugsIt was revealed that this year will be introduced a new management of basic drugs management, and put forward the combination of basic drugs and chronic long prescription policy recommendations, the development of the core drug catalogBase drug or this year's update management methods, next year to adjust the catalog outflow of the meeting news shows: the National Health and Health Commission this year will introduce a new management of basic drugs, is seeking the views of the provinces; In 2018, a new version of the national list of basic medicines was released, and the varieties expanded from 520 to 685Unlike the previous edition, in principle, drugs cannot be added to the 2018 national catalogueIn 2019, the National Health Insurance Administration issued a letter abolishing the local supplement of the base medicine, and the national unified national list of basic medicines was formally formedIn accordance with the Opinions of the General Office of the State Council on the Improvement of the National Basic Drug System, the list of essential drugs will be regularly evaluated and dynamically adjusted, and the adjustment cycle shall not exceed three years in principleThe year 2021 will reach a three-year cycle, with an updated "base medicine catalogue" next yearIt is worth noting that the meeting also put forward a combination of base drugs and chronic long prescription policy, the development of the core drug catalog of basic drugsWhich varieties will be included in the principles developed in the core drug catalog of the base drug? There was no clear explanation, but perhaps some answers were found in the notice issued by the National Health and Care Commission to further strengthen the management of the use of essential drugs in public medical institutionsThe circular has made it clear that all localities should combine the basic drug system with the construction of the medical association ( total) medical association, graded diagnosis and treatment, family doctor contract inglision services, chronic disease health management and so on, and explore ways to reduce the burden of patients' drug costs, enhance the public's access to drugs, and play the role of essential drugs in reducing drug costs and rational drug useLong prescription drugs included in the core drug catalog? And high blood pressure, diabetes and other chronic diseases and long prescription drug catalog is also consistent, the high probability of the relevant drugs will enter the core drug catalogAccording to the State Council's latest "Notice on the Administration of Long-Term Prescriptions for Current Chronic Diseases" issued by the Medical Treatment Group of the State Council's Joint Prevention and Control Mechanism for the New Crown Epidemic, we encourage the formulation and improvement of long-term prescription management policies for chronically ill patients, and make clear the requirements for the catalogue of diseases, the scope of drug use, management system and safety notification seeking long-term prescriptions, so as to reduce the number of patients taking medicineMedical institutions should take effective measures to meet the medical service needs of patients with chronic diseases who need long-term drug use (including narcotic drugs, psychotropic drugs and other special drugs), hemodialysis and other special treatment, and may prescribe drugs for up to 12 weeks at a time for patients with chronic diseases with stable conditionsNot long ago, Hainan, as the first province to publish the Long-Term Prescription Drug Catalog (Trial), included 137 drugs in 9 categories of long-term prescription drugs, including hypertension, diabetes, abnormal blood lipids, copble, chronic kidneys, stroke, chronic prostate, chronic heart failure, and other commonly used chronic diseasesAt the same time, Hainan requires medical institutions to draw up a catalogue of long-term prescriptions for diseases and drugs in accordance with the actual situation, giving priority to the national medical insurance drug catalogue, the national list of essential drugs and the drugs purchased centrally by the stateIn other words, the long-prescribed drug catalogue will give preference to the national base drug catalogue, but not limited to the base drug catalogueHowever, it can also be observed that the policy of base medicine and long prescription is consistent with the push-off of the hierarchical diagnosis and treatment system The proportion of use and supporting measures are the key policies to encourage the use of base drugs, and the status of base drugs in medical institutions is becoming more and more important In February this year, the National Health and Health Commission and other six departments formulated the "Opinion on strengthening the management of medicines in medical institutions to promote rational use of drugs" stressed that the clear dynamic adjustment of the national list of essential drugs, to promote medical institutions at all levels to form a basic drugs-led "1 plus X" drug use model And since the introduction of the 2018 version of the base drug catalog, the frequency of the use of basic drugs increased significantly The "China Pharmaceutical Society Hospital Drug Monitoring Report - Chemical and Biological Products Part 2019" released by the Chinese Pharmaceutical Society analyzed the use of essential drugs, with the sample hospital level being the second and third levels The report shows a slight decrease in the proportion and frequency of essential drug use in 2014-2018 After the adjustment of the National Essential Medicines Directory in 2018, the proportion of basic drug use in hospitals at all levels has increased The number of essential drug use rules increased from 783 to 1052, the proportion of the amount increased from 12.1% to 27.2%, the frequency of use increased from 31.3% to 47.1%, and the average daily cost increased from $5 to $7.5 In terms of the proportion of use amount, the gap between the second and third level hospitals is narrowing Based on the data for the first half of 2019, compared with the National Essential Medicines Catalog (2012 Edition) and the National Essential Medicines Directory (2018 Edition), the overall drug regulations for essential drugs increased by 34.4%, the overall amount increased by 124.7%, and the overall frequency of use increased by 50.8% With the continuous expansion of the base drug, the number of base drugs more and more, the development of the core drug catalog of the base drug will have an impact on the entire base drug market? This key will probably be related to the proportion of the core drug catalogue of the base drug and the supporting use measures, in particular whether new requirements will be made for the proportion of hospitals at all levels In the industry's view, the long-term prescription policy is conducive to increase the continuity and compliance of drug use, into the long prescription drug catalog of drugs will usher in some new market opportunities, into the core drug catalog varieties, since the emphasis on the core of this principle, the market is good naturally self-evident According to the long prescription catalog range, like Hainan announced 137 species, from the number of varieties, accounting for 685 kinds of base drugs is not a high proportion The prospects for the relevant base drug species may also be a cause for concern if they do not enter the core drug catalog, as the use of the drug has been poorly used in hospitals at a low price
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.